false
0001392380
0001392380
2026-07-13
2026-07-13
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 13, 2026
Gevo, Inc.
(Exact name of registrant as specified in its charter)
| Delaware |
001-35073 |
87-0747704 |
| (State or other jurisdiction |
(Commission File Number) |
(IRS Employer |
| of incorporation) |
|
Identification No.) |
|
345
Inverness Drive South, Building
C, Suite 310,
Englewood, CO 80112 |
| (Address of principal
executive offices)(Zip Code) |
Registrant’s telephone number, including area code: (303) 858-8358
N/A
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class |
|
Trading symbol |
|
Name of exchange on which registered |
| Common Stock, par value $0.01 per share |
|
GEVO |
|
The Nasdaq
Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers. |
Effective as of August 20, 2026, the Board of Directors (the “Board”)
of Gevo, Inc. (“Gevo” or the “Company”) approved the appointment of Todd Werpy to the Board as a Class II
director, with a current term that will expire at the annual meeting of stockholders to be held in 2027. Mr. Werpy will receive an
annual cash retainer of $85,000 and an equity grant valued at $94,500 for service as a non-employee director, subject to the Company’s
compensation policy for non-employee directors as specified from time to time by the Board. The equity award will be made pursuant to
the Company’s Amended and Restated 2010 Stock Incentive Plan. Mr. Werpy will also be eligible to receive annual grants of equity
and other compensation consistent with the Company’s compensation policy for his service as a non-employee director, as specified
from time to time by the Board. Mr. Werpy also entered into the Company’s customary form of indemnification agreement upon
his appointment to the Board.
There are no understandings or arrangements with any person pursuant
to which Mr. Werpy was selected as a director, and Mr. Werpy is not party to any related party transaction required to be reported
pursuant to Item 404(a) of Regulation S-K.
The Board considered the independence of Mr. Werpy under The Nasdaq
Stock Market LLC (“Nasdaq”) listing standards and concluded that Mr. Werpy is an independent director under the applicable
Nasdaq standards.
The Company issued the press release attached hereto as Exhibit 99.1
in connection with the appointment of Mr. Werpy to the Board.
The information included in this Current Report under Item 7.01, including
Exhibit 99.1, is deemed to be “furnished” and shall not be “filed” for purposes of Section 18 of the
Exchange Act, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing under the
Securities Act or the Exchange Act.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
|
Description |
| 99.1 |
|
Press Release, dated July 16, 2026 |
| 104 |
|
Cover Page Interactive Data File (Formatted as Inline XBRL) |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
GEVO, INC. |
| |
|
|
| Date: July 16, 2026 |
By: |
/s/ E. Cabell Massey |
| |
|
E. Cabell Massey |
| |
|
Vice
President, Deputy General Counsel and Corporate Secretary |
Exhibit 99.1
|
345 Inverness Drive South
Building C, Suite 310
Englewood, CO 80112 |
t 303-858-8358
f 303-858-8431
gevo.com |
FOR IMMEDIATE RELEASE
Gevo Announces Appointment of Todd Werpy to
Board of Directors
ENGLEWOOD,
Colo. – July 16, 2026 – Gevo, Inc. (NASDAQ: GEVO), a leader in renewable fuels, chemicals and carbon
management, today announced the appointment of Todd Werpy, Ph.D. to its Board of Directors. Werpy brings more than three decades of innovation
and executive leadership experience spanning sustainable technologies, global research and development, manufacturing operations, and
enterprise transformation.
“Todd is a highly respected leader whose unique combination of
scientific expertise, operational discipline and commercial execution will be a tremendous asset to Gevo,” said Gevo Chief
Executive Officer Paul Bloom. “As we continue to build our business focused on low-carbon fuels, renewable chemicals, carbon management,
and sustainable growth, we believe Todd’s experience scaling technology, modernizing operations and transforming complex manufacturing
organizations will strengthen our Board and help guide Gevo’s next phase of value creation.”
A recognized scientist, innovator and business leader, Werpy most
recently served as Chief Science Officer and a member of the Executive Committee at Archer-Daniels-Midland Company (ADM) where he helped build a strong technology pipeline that generated significant enterprise value through innovation, commercialization
and strategic partnerships. He also was an executive leader supporting modernization programs involving automation, advanced process controls
and analytics that delivered significant returns while improving productivity, reliability, and sustainability. His expertise spans biotechnology,
catalysis, process engineering and commercialization of bio-based technologies.
“Gevo has built a strong foundation of technologies, assets and
capabilities that can help address some of the most important challenges facing markets today,” said Werpy. “I am honored
to join the Board and look forward to working alongside my fellow directors and the management team to support Gevo’s continued
growth and long-term success.”
Werpy holds a Ph.D. in Inorganic Chemistry from Michigan State University
and is a graduate of the Harvard Business School Executive Leadership Program. He holds 36 U.S. patents and more than 100 patents globally
and is the recipient of the American Chemical Society’s Green Chemistry Award. He is also widely recognized as a co-author of the
U.S. Department of Energy report, Top 12 Value-Added Chemicals from Biomass.
The addition of Todd Werpy to the Gevo Board of Directors is effective
August 20.
About Gevo
Gevo is a next-generation diversified energy company committed to fueling
America’s future with cost-effective, drop-in fuels that contribute to energy security, abate carbon, and strengthen rural communities
to drive economic growth. Gevo’s innovative technology can be used to make a variety of renewable products, including sustainable
aviation fuel (SAF), motor fuels, chemicals, and other materials that provide U.S.-made solutions. Gevo’s business model includes
developing, financing, and operating production facilities that create jobs and revitalize communities. Gevo owns and operates an ethanol
plant with an adjacent carbon capture and storage (CCS) facility and Class VI carbon-storage well. Gevo also owns and operates one
of the largest dairy-based renewable natural gas (RNG) facilities in the United States, turning by-products into clean, reliable energy.
Additionally, Gevo developed the world’s first production facility for specialty alcohol-to-jet (ATJ) fuels and chemicals operating
since 2012. Gevo is currently developing the world’s first large-scale ATJ facility to be co-located at our North Dakota site. Gevo’s
market-driven “pay-for-performance” approach regarding carbon and other sustainability attributes helps deliver value to our
local economies. Through its Verity subsidiary, Gevo provides transparency, accountability, and efficiency in tracking, measuring, and
verifying various attributes throughout the supply chain. By strengthening rural economies, Gevo is working to secure a self-sufficient
future and to make sure value is brought to the market.
For more
information, please go to www.gevo.com.
Forward-Looking Statements
Certain statements in this press release may constitute “forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, without limitation, including the appointment
of Todd Werpy, and other statements that are not purely statements of historical fact. These forward-looking statements are made on the
basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty.
Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak
only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new
information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are
reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be
expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual
results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general,
see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2025, and in subsequent reports
on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.
Media
Contact
Communications@gevo.com
IR Contact
IR@Gevo.com